VCYT
Veracyte Inc
45.80$
+3.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +9.0% | -1.4% | +18.2% | +1.3% | +2.4% | -3.5% | +13.7% | +1.3% | +6.6% | -1.1% | +8.1% | – | |
| – | +6.4% | +17.0% | +6.2% | +0.9% | +8.2% | -12.3% | +15.5% | +0.5% | -11.4% | +7.1% | +8.5% | – | |
| – | +10.1% | -9.2% | +24.7% | +1.4% | -0.3% | +1.0% | +12.9% | +1.7% | +14.7% | -3.9% | +7.9% | – | |
| – | +40.2% | -14.5% | +3.1% | +6.7% | +9.8% | -8.1% | -8.2% | -1.7% | +30.5% | +30.0% | +8.7% | – | |
| – | +151.7% | +4.3% | +9.6% | -13.9% | +16.5% | +11.1% | -73.6% | +213.3% | -96.7% | +1,571.1% | +15.9% | – | |
| – | +10.7% | -35.7% | +9.2% | -8.6% | +11.3% | +2.7% | +24.1% | -28.1% | +15.2% | -2.5% | +11.5% | – | |
| – | – | – | – | +160.9% | -65.3% | -30.4% | -281.4% | – | +13.0% | -8.1% | -3.6% | – | |
| – | +0.0% | -100.0% | – | +0.0% | -100.0% | – | – | – | – | – | – | – | |
| – | – | – | – | +128.9% | -79.6% | +115.7% | -83.2% | +1,411.1% | +115.1% | -26.2% | -35.1% | – | |
| – | – | – | – | +4.1% | -198.6% | – | +485.3% | -111.1% | – | – | -577.3% | – | |
| – | – | – | – | +164.3% | -66.3% | +37.8% | -113.9% | – | +115.0% | -30.2% | -11.2% | – | |
| – | – | – | +576.0% | +73.5% | -57.3% | -32.7% | +3.3% | +258.4% | +90.2% | -22.9% | -31.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.